Monotherapy for the treatment of amyotrophic lateral sclerosis with cyclooxyge-nase-2 (cox 2) inhibitor(s)

Details for Australian Patent Application No. 2003232096 (hide)

Owner PHARMACIA CORPORATION

Inventors Isakson, Peter C.

Agent Freehills

Pub. Number AU-A-2003232096

PCT Number PCT/US03/14548

PCT Pub. Number WO2003/101441

Priority 60/384,139 31.05.02 US; 10/444,072 23.05.03 US

Filing date 28 May 2003

Wipo publication date 19 December 2003

International Classifications

A61K 031/16 - Amides, e.g. hydroxamic acids

Event Publications

28 August 2003 Complete Application Filed

  Priority application(s): 60/384,139 31.05.02 US; 10/444,072 23.05.03 US

12 February 2004 Application Open to Public Inspection

  Published as AU-A-2003232096

4 January 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003232097-A TRANSDUCER WITH MULTIPLE RESONANT FREQUENCIES FOR AN IMAGING CATHETER

2003232095-METHODS FOR PREPARING AGGLOMERATED PELLETS OF POLYTETRAFLUOROETHYLENE AND MOLDED ARTICLES THEREOF